The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma

The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma

Objective: This study aimed to evaluate the applicability of adenosine deaminase (ADA), α-l-fucosidase (AFU), lactic acid (LAC), and their combined detection in the early diagnosis of chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC).Methods: A retrospective analysi...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Zhong Chen, Chengjun Xue, Yao Zhang, Lipei Wu, Jichao Zhu, Shihai Xuan, Jiale Tian, Zhi Pang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
ADA
AFU
LAC
hepatitis
liver cirrhosis
hepatocellular carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.740029/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.740029/full

Similar Items